Protagonist Therapeutics, Inc. (PTGX)
134.58
+5.83
(+4.53%)
USD |
NASDAQ |
Oct 19, 16:00
134.58
0.00 (0.00%)
After-Hours: 20:00
Protagonist Therapeutics Price : 134.58 for Oct. 19, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 136.16 | 136.56 | 126.39 | 128.75 | 886813.0 |
| Oct 15, 2026 | 136.72 | 139.11 | 136.02 | 136.55 | 707740.0 |
| Oct 14, 2026 | 138.06 | 141.13 | 135.62 | 136.28 | 679101.0 |
| Oct 13, 2026 | 146.00 | 146.00 | 137.81 | 138.49 | 1.032M |
| Oct 12, 2026 | 145.83 | 152.18 | 143.69 | 144.88 | 898518.0 |
| Oct 09, 2026 | 139.91 | 146.30 | 138.95 | 143.73 | 763099.0 |
| Oct 08, 2026 | 139.57 | 142.18 | 137.99 | 139.91 | 1.000M |
| Oct 07, 2026 | 137.34 | 144.10 | 137.25 | 140.92 | 927270.0 |
| Oct 06, 2026 | 140.34 | 141.00 | 136.09 | 138.69 | 635716.0 |
| Oct 05, 2026 | 139.96 | 142.51 | 138.08 | 140.63 | 1.274M |
| Oct 02, 2026 | 140.99 | 141.71 | 138.37 | 140.06 | 760304.0 |
| Oct 01, 2026 | 139.23 | 143.68 | 138.37 | 139.19 | 886246.0 |
| Sep 30, 2026 | 141.60 | 143.74 | 140.44 | 140.89 | 787658.0 |
| Sep 29, 2026 | 143.45 | 144.09 | 138.88 | 140.97 | 508014.0 |
| Sep 28, 2026 | 142.21 | 143.68 | 140.24 | 142.44 | 925462.0 |
| Sep 25, 2026 | 141.81 | 143.45 | 138.23 | 141.86 | 809293.0 |
| Sep 24, 2026 | 138.76 | 140.80 | 134.10 | 137.34 | 989225.0 |
| Sep 23, 2026 | 144.27 | 145.28 | 137.88 | 138.70 | 513226.0 |
| Sep 22, 2026 | 144.64 | 147.71 | 144.50 | 145.07 | 806176.0 |
| Sep 21, 2026 | 143.22 | 145.37 | 141.09 | 144.98 | 822199.0 |
| Sep 18, 2026 | 143.09 | 144.58 | 140.44 | 143.00 | 1.837M |
| Sep 17, 2026 | 144.39 | 146.50 | 142.31 | 143.70 | 558901.0 |
| Sep 16, 2026 | 144.19 | 146.19 | 140.88 | 142.84 | 507312.0 |
| Sep 15, 2026 | 147.48 | 147.99 | 142.00 | 143.40 | 637522.0 |
| Sep 14, 2026 | 150.23 | 151.24 | 146.83 | 147.78 | 608017.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Johnson & Johnson | 254.05 |
| AbbVie, Inc. | 282.68 |
| Gilead Sciences, Inc. | 153.12 |
| Alnylam Pharmaceuticals, Inc. | 233.37 |
| BioMarin Pharmaceutical, Inc. | 54.66 |
Price Related Metrics
| PE Ratio | 129.78 |
| PS Ratio | 32.13 |
| PEG Ratio | 2.850 |
| Price to Book Value | 10.34 |
| Price to Free Cash Flow | 69.39 |
| Earnings Yield | 0.77% |
| Market Cap | 8.704B |
| PEGY Ratio | 2.850 |
| Operating PE Ratio | 155.30 |
| Normalized PE Ratio | 129.77 |